My Precision Oncology Program (MyPOP)

The Vancouver Prostate Centre's MyPOP (My Precision Oncology Program) is a recently launched clinical research program which strives to better deliver personalized therapeutics to patients with advanced or treatment-resistant cancer of the prostate, kidney or bladder.

The program is currently available only to patients of the VPC or BCCA who meet specific clinical trial criteria.

The program's objectives are to:

  • Develop standardized procedures to enable routine linking of genomic sequencing data with clinical decision making,
  • Integrate research and development of plasma DNA and RNA assays into clinical practice, and
  • Integrate clinical information with novel model systems

A schematic overview of the program is below:

MyPOP Schematic

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

It's A Snow Day

It's A Snow Day: Friday March 8

It's A Snow Day at Mt. Seymour, a fundraiser for Prostate Cancer Foundation BC, is being held on Friday March 8, 2019. Visit the event website for more details, and to register and/or sponsor a participant, or donate directly to Prostate Cancer Foundation BC.

10th Anniversary Ride to Live

West Coast Motorcycle Ride To Live: May 26th

The 10th Anniversary West Coast Motorcycle Ride to Live is taking place in Vancouver and the Fraser Valley on May 26 (Victoria date to be finalized), with details on the event and how to register on the event website.  This fundraiser for Prostate Cancer Foundation BC includes a 50/50 raffle open to all BC residents over age 19.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development